HomeIPSC • NASDAQ
add
Century Therapeutics Inc
Previous close
$0.99
Day range
$0.94 - $1.01
Year range
$0.94 - $5.51
Market cap
80.15M USD
Avg Volume
729.66K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 791.00K | 434.46% |
Operating expense | 8.35M | -7.06% |
Net income | -31.23M | 4.57% |
Net profit margin | -3.95K | 82.14% |
Earnings per share | -0.37 | 32.73% |
EBITDA | -31.49M | -11.37% |
Effective tax rate | 0.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 198.11M | 16.88% |
Total assets | 388.62M | -2.25% |
Total liabilities | 192.93M | 8.19% |
Total equity | 195.69M | — |
Shares outstanding | 85.03M | — |
Price to book | 0.43 | — |
Return on assets | -21.61% | — |
Return on capital | -32.90% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -31.23M | 4.57% |
Cash from operations | -28.33M | -107.58% |
Cash from investing | 39.20M | 829.55% |
Cash from financing | 273.00K | -9.00% |
Net change in cash | 11.14M | 221.99% |
Free cash flow | -14.58M | 0.12% |
About
Founded
2018
Headquarters
Website
Employees
152
